Immunome Inc. (IMNM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
11.59
1.44 (14.13%)
At close: Sep 26, 2025, 3:59 PM
11.70
0.94%
After-hours: Sep 26, 2025, 07:59 PM EDT

Immunome Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
143.35M 98.68M 20.32M 49.23M
Short-Term Investments
73.95M 39.46M n/a n/a
Long-Term Investments
100K 100K 100K 100K
Other Long-Term Assets
4.41M 100K 332K 332K
Receivables
n/a 289K 847K 4.31M
Inventory
n/a n/a n/a n/a
Other Current Assets
4.04M 4.99M n/a n/a
Total Current Assets
221.34M 144.7M 22.65M 56.64M
Property-Plant & Equipment
14.39M 3.64M 965K 855K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
18.9M 3.84M 1.4M 1.29M
Total Assets
240.24M 148.54M 24.05M 57.92M
Account Payables
14.19M 3.31M 2.4M 3.08M
Deferred Revenue
6.94M 10.49M n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
33.11M 4.98M 1.96M 2.02M
Total Current Liabilities
54.31M 21.83M 7.33M 9.73M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 5.49M n/a 12K
Total Long-Term Liabilities
4.77M 6.83M 62K 12K
Total Liabilities
59.08M 28.66M 7.39M 9.74M
Total Debt
4.83M 1.65M 291K 317K
Book Value
181.16M 119.88M 16.65M 48.19M
Book Value Per Share
3.09 6.04 1.37 4.18
Common Stock
6K 4K 1K 1K
Retained Earnings
-515.77M -222.81M -116M -79.11M
Comprehensive Income
57K 22K n/a -57.92M
Shareholders Equity
181.16M 119.88M 16.65M 48.19M
Total Investments
73.95M 39.56M 100K 100K